Transtympanic versus sustained-release administration of gentamicin: Kinetics, morphology, and function

Laryngoscope

Volumn 111, Issue 8, 2001, Pages 1343-1357

  Hoffer, Michael E ^a   Allen, Keith ^a   Kopke, Richard D ^a   Weisskopf, Peter ^a   Gottshall, Kim ^a   Wester, Derin ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

Apoptosis; Gentamicin; Meniere's disease; Ototoxic; Transtympanic

Indexed keywords

CASPASE 3; CASPASE 7; GENTAMICIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY EQUILIBRIUM; CELL STRUCTURE; CHINCHILLA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEVICE; FEMALE; HAIR CELL; HEARING LOSS; HEARING TEST; IMMUNOHISTOCHEMISTRY; INNER EAR; INTERMETHOD COMPARISON; MENIERE DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RELIABILITY; SPIRAL GANGLION; SUSTAINED DRUG RELEASE;

EID: 0034905870     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200108000-00007     Document Type: Article

References (76)

1. The incidence and prevalence of Meniere's disease: A statistical analysis of limits
2. Bilateral aspects of Meniere's disease: An underestimated clinical entity
3. Molecular and cellular pathology of Meniere's disease
4. The history of Meniere's disease
5. Medical treatment of Meniere's disease
6. The role of allergy in Meniere's disease
7. The treatment of Meniere's disease
8. Ablation therapy for the relief of Meniere's disease
9. The saccus endolymphaticus and an operation for draining the same for the relief of vertigo
10. Endolymphatic sac surgery in Meniere's disease
11. Pathophysiologic theories in the etiology of Meniere's disease
12. Intracranial division of the vestibular portion of the auditory nerve for Meniere's disease
13. The surgical treatment of Meniere's disease
14. Surgical exposure of the internal auditory canal and its contents through the middle cranial fossa
15. Retrolabyrinthine surgery: A direct approach to the cerebellopontine angle
16. Retrosigmoid-internal auditory canal approach vs. retrolabyrinthine approach for vestibular neurectomy
17. Combined retrolab-retrosigmoid vestibular neurectomy: An evolution in approach
18. Streptomycin treatment of vertigo
19. Use of streptomycin sulfate in the treatment of Meniere's disease
20. Bilateral Meniere's disease: Treatment with intramuscular titration streptomycin sulfate
21. Ablation therapy in Meniere's disease
22. Intratympanic application of gentamicin for treatment of Meniere's disease
23. Middle ear ototoxic treatment for inner ear disease
24. Treatment of Meniere's disease with topical gentamicin: A preliminary report
25. Ten years of experience with intratympanically applied streptomycin (gentamycin) in the therapy of Morbus Meniere
26. Intratympanic gentamicin treatment for Meniere's disease
27. Intratympanic gentamicin for control of vertigo in Meniere's disease: Vestibular signs that specify completion of therapy
28. Intratympanic gentamicin in bilateral Meniere's disease
29. Intratympanic gentamicin for treatment of intractable Meniere's disease: A preliminary report
30. Vestibular and audiologic functions in gentamicin-treated Meniere's disease
31. Intratympanic gentamicin therapy for Meniere's disease: Preliminary comparison of two regimens
32. Low-dose intratympanic gentamicin and the treatment of Meniere's disease: Preliminary results
33. Transtympanic gentamicin for Meniere's syndrome
34. Pharmacokinetics and ototoxicity of gentamicin, tobramycin, and amikacin
35. Aminoglycoside ototoxicity: Influence of dosage regimen on drug uptake and correlation between membrane binding and some clinical features
36. Cochlear permeability of neomycin and gentamicin: An immunohistochemical study
37. Early effects of gentamicin on inner ear glycocalyx cytochemistry
38. Gentamicin uptake by cochlear hair cells precedes hearing impairment during chronic treatment
39. Kinetics of gentamicin uptake in the inner ear of Chinchilla laniger after middle-ear administration in a sustained-release vehicle
40. Results of clinical, electrophysiological and histological investigations of gentamicin ototoxicity
41. Histopathological findings in clinical gentamicin ototoxicity
42. Use of a new device, the MicroWick, to deliver medication to the inner ear
43. Clinical results with the round window microcatheter and microdose gentamicin in the treatment of Meniere's disease
44. Round-window microcatheter-administered microdose gentamicin: Results from treatment of tinnitus associated with Meniere's disease
45. Immunohistochemical study of intermediate filament proteins on routinely processed, celloidin-embedded human temporal bone sections by using a new technique for antigen retrieval
46. Comparative ototoxicity of aminoglycoside antibiotics in a guinea pig model
47. Pharmacokinetics of gentamicin in perilymph and endolymph of the rat as determined by radioimmunoassay
48. Kinetics of gentamicin uptake and release in the rat: Comparison of inner ear tissues and fluids with other organs
49. Myosin VIIA is required for aminoglycoside accumulation in cochlear hair cells
50. Radioactive labeling of phospholipids and proteins by cochlear perfusion in the guinea pig and the effect of neomycin
51. Continuous intratympanic gentamycin infusion in Meniere disease
52. Experimental study of the transfer of kantamycin to the inner ear fluids
53. Gentamycin in distributive balance between serum, perilymph and liquor in guinea-pig after dosage in therapeutical range
54. Morphologic changes in the inner ear of Chinchilla laniger after middle ear administration of gentamicin in a sustained-release vehicle
55. Ethacrynic acid facilitates gentamicin entry into endolymph of the rat
56. Gentamicin persistence in rat endolymph and perilymph after a two-day constant infusion
57. Drug ototoxicity
58. Action toxique vestibulaire et cochleaire de lastreptomycine au point de vue experimental
59. Further Observations concerning the toxic effects of streptomycin and quinine on the auditory organ of guinea pigs
60. Gentamicin ototoxicity: Histological and ultrastructural alterations after transtympanic administration
61. Dose-related vestibular and cochlear effects of transtympanic gentamicin
62. Two modes of hair cell loss from the vestibular sensory epithelia of the guinea pig inner ear
63. Structural damage to the organ or Corti and the vestibular epithelia caused by aminoglycoside antibiotics in the guinea pig
64. Apoptotic death of hair cells in mammalian vestibular sensory epithelia
65. Gentamicin ototoxicity induced apoptosis of the vestibular hair cells of guinea pigs
66. Calpain inhibitors protect auditory sensory cells from hypoxia and neurotrophin-withdrawal induced apoptosis
67. Caspase inhibitors prevent cisplatin-induced apoptosis of auditory sensory cells
68. Cell turnover in neuromasts of zebra fish larvae
69. Cochlear neural degeneration without hair cell loss in two patients with aminoglycoside ototoxicity
70. Loss of spiral ganglion cells as primary manifestation of aminoglycoside ototoxicity
71. Aminoglycoside-induced cochlear pathology in man
72. Cochlear pathology of long-term neomycin induced deafness in cats
73. Spiral ganglion neuron loss following organ of corti loss
74. Evaluation of the effect of ototopical neomycin on spiral ganglion cell density in the guinea pig
75. Patterns of neural degeneration in the human cochlea and auditory nerve: Implications for cochlear implantation
76. Middle ear instillation of gentamicin and streptomycin in chinchillas: Morphologic appraisal of selective ototoxicity